JH-XI-10-02 is primarily utilized in the field of medicinal chemistry for its potential as a therapeutic agent. It has shown promising activity in targeting specific biological pathways, making it a candidate for drug development in areas such as oncology and autoimmune diseases. Researchers are exploring its efficacy in inhibiting certain enzymes or proteins that play a critical role in disease progression. Additionally, its unique structural properties allow for further chemical modifications, enabling the development of derivatives with enhanced pharmacological profiles. Preclinical studies are ongoing to evaluate its safety, bioavailability, and therapeutic potential, with the aim of advancing it to clinical trials.